New Joint Injection Options Now Available: Cingal, Monovisc and Orthovisc
Dr Jones is pleased to now offer Cingal, Monovisc and Orthovisc as part of his injection treatment options for selected patients with joint pain and osteoarthritis.
These treatments belong to a family of hyaluronic acid-based injections with a long clinical heritage, supported by more than 25 million injections worldwide across the wider product range.
The introduction of these options gives patients access to a broader choice of non-surgical treatments, with different injections available depending on the joint involved, the level of pain, the presence of inflammation and the overall treatment goal.
Expanding treatment choice for joint pain
Joint pain and osteoarthritis can affect people in different ways.
Some patients mainly struggle with stiffness, aching and reduced confidence in the joint. Others experience more irritated, inflamed or painful flare-ups, where the joint feels swollen, reactive or difficult to settle.
Because symptoms vary from person to person, it is helpful to have a family of treatment options rather than relying on a single approach.
By offering Cingal, Monovisc and Orthovisc, Dr Jones can discuss which injection may be most suitable based on the joint being treated, the stage of symptoms, examination findings and the patient’s goals.
What is hyaluronic acid?
Hyaluronic acid is a naturally occurring substance found in healthy joints.
It plays an important role in helping the joint move smoothly by supporting lubrication, cushioning and the quality of the joint environment.
In osteoarthritis, the natural hyaluronic acid within the joint can become reduced or less effective. This may contribute to pain, stiffness and reduced movement.
Hyaluronic acid injections are designed to supplement the joint and support smoother, more comfortable movement.
What is Monovisc?
Monovisc is a single-injection hyaluronic acid treatment used to help manage symptoms associated with osteoarthritis. Its formulation is specifically designed to be optimised for a longer-lasting effect that is safe, with fewer potential painful flares.
It is designed to support the joint environment by helping with lubrication, cushioning and comfort during movement.
Monovisc may be considered for patients with osteoarthritis-related joint pain where the main aim is to improve comfort, mobility and confidence with activity.
It may be particularly useful where symptoms are more mechanical, stiff or movement-related, rather than dominated by an inflamed flare-up.
What is Orthovisc?
Orthovisc is another hyaluronic acid injection option and can be particularly useful when considering treatment for smaller joints.
Smaller joints can still cause significant pain and loss of function, especially in areas such as the hand, wrist, thumb, foot, ankle or other joints where movement and grip matter in daily life.
Orthovisc gives Dr Jones another option to discuss where hyaluronic acid treatment may be appropriate, but where the size or nature of the joint means a different approach may be needed.
As with all injection treatments, suitability depends on the diagnosis, symptoms, examination findings and treatment goals.
What is Cingal?
Cingal is a combined injection that contains hyaluronic acid alongside an anti-inflammatory component, which gives patients a unique result of pain relief that can start within 48hrs but lasts beyond 6 months.
This makes it different from a standard hyaluronic acid-only injection.
Cingal may be considered when osteoarthritis symptoms involve both the mechanical side of joint pain and the more irritated, inflamed side of the condition.
In simple terms, it is designed to help address pain, synovitis and inflammation, while also supporting the joint environment in a way that may help improve comfort, movement and function.
This makes Cingal a useful option to discuss when a joint feels swollen, reactive, painful or difficult to settle, as well as stiff or limited.
Why Cingal may be different
Osteoarthritis is not always just “wear and tear”.
For many patients, symptoms can involve inflammation of the joint lining, known as synovitis. This can contribute to pain, swelling, warmth, stiffness and flare-ups.
Cingal is currently the only option within this family that combines hyaluronic acid with an anti-inflammatory component in a single injection.
That means it can be considered when the aim is to help calm the irritated, inflamed joint while also supporting lubrication, cushioning and better movement.
For the right patient, this can make it a valuable treatment option, particularly when inflammation and pain are limiting activity or slowing progress with rehabilitation.
Cingal, Monovisc or Orthovisc: which is right for me?
The most suitable injection depends on the joint being treated and the type of symptoms you are experiencing.
Monovisc may be considered when the main aim is to support joint lubrication, cushioning and movement in osteoarthritis.
Orthovisc may be useful when treating smaller joints or where a different hyaluronic acid option is more appropriate.
Cingal may be considered when pain, inflammation, synovitis or flare-up symptoms are a more prominent part of the problem, while still aiming to support joint function and movement.
The right choice should always be based on a proper assessment, not simply on the name of the injection.
A personalised approach to injection treatment
Injection treatment works best when it forms part of a wider plan.
For some patients, this may include physiotherapy, strengthening work, activity modification, bracing, medication advice, imaging or lifestyle changes.
The aim is not just to offer an injection, but to choose the right treatment for the right patient at the right time.
Dr Jones will assess your symptoms, explain the available options and discuss whether Cingal, Monovisc, Orthovisc or another treatment approach may be suitable.
Book an appointment
If you are struggling with joint pain, stiffness, swelling or osteoarthritis symptoms, Dr Jones can assess your condition and discuss whether injection treatment may be appropriate.
Cingal, Monovisc and Orthovisc are now available as part of his treatment options for selected patients.
